Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity

NCT03795701 is registered in ClinicalTrials.gov with Texas Tech University as lead sponsor.

NCT NCT03795701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03795701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
Lead sponsor
Texas Tech University
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2019
Completion date
May 1, 2022
Enrollment
73 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obesity